CORCEPT THERAPEUTICS INC Increase (Decrease) in Other Current Liabilities
CORCEPT THERAPEUTICS INC (CORT) reported Increase (Decrease) in Other Current Liabilities of -$1.26 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2022-02-15
- CORCEPT THERAPEUTICS INC increase (decrease) in other current liabilities for the quarter ending 2018-06-30 was $1.91M, a 3722.00% increase year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in other current liabilities for the quarter ending 2018-03-31 was $1.24M.
- CORCEPT THERAPEUTICS INC increase (decrease) in other current liabilities for the quarter ending 2017-12-31 was $355.00K.
- CORCEPT THERAPEUTICS INC increase (decrease) in other current liabilities for the quarter ending 2017-09-30 was $381.00K, a 53.08% decline year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in other current liabilities for fiscal 2021 was -$1.26M, a 117.46% decline from fiscal 2020.
- CORCEPT THERAPEUTICS INC increase (decrease) in other current liabilities for fiscal 2020 was $7.23M, a 144.49% increase from fiscal 2019.
- CORCEPT THERAPEUTICS INC increase (decrease) in other current liabilities for fiscal 2019 was $2.96M, a 132.03% increase from fiscal 2018.
- CORCEPT THERAPEUTICS INC increase (decrease) in other current liabilities for fiscal 2018 was $1.27M, a 63.33% increase from fiscal 2017.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$1.26M 10-K · filed 2022-02-15 | |||
| 2020-12-31 | $7.23M 10-K · filed 2022-02-15 | |||
| 2019-12-31 | $2.96M 10-K · filed 2022-02-15 | |||
| 2018-12-31 | $1.27M 10-K · filed 2021-02-23 | |||
| 2018-06-30 | $1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $3.15M 10-Q · filed 2018-08-09 | $3.50M derived: sum of 3 quarters · filed 2020-02-24 | $3.89M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $1.24M 10-Q · filed 2018-05-09 | $1.59M derived: sum of 2 quarters · filed 2020-02-24 | $1.98M derived: sum of 3 quarters · filed 2020-02-24 | $2.02M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $736.00K derived: sum of 2 quarters · filed 2020-02-24 | $786.00K derived: sum of 3 quarters · filed 2020-02-24 | $780.00K 10-K · filed 2020-02-24 |
| 2017-09-30 | $381.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $431.00K derived: sum of 2 quarters · filed 2018-08-09 | $425.00K 10-Q · filed 2017-11-03 | $117.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $44.00K 10-Q · filed 2018-08-09 | -$264.00K derived: sum of 3 quarters · filed 2019-02-26 | $548.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | -$6.00K 10-Q · filed 2018-05-09 | -$314.00K derived: sum of 2 quarters · filed 2019-02-26 | $498.00K derived: sum of 3 quarters · filed 2019-02-26 | $367.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | -$308.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $504.00K derived: sum of 2 quarters · filed 2019-02-26 | $373.00K derived: sum of 3 quarters · filed 2019-02-26 | $296.00K 10-K · filed 2019-02-26 |
| 2016-09-30 | $812.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $681.00K derived: sum of 2 quarters · filed 2017-11-03 | $604.00K 10-Q · filed 2017-11-03 | $1.17M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | -$131.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$208.00K 10-Q · filed 2017-08-02 | $354.00K derived: sum of 3 quarters · filed 2018-02-28 | $471.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | -$77.00K 10-Q · filed 2017-05-02 | $485.00K derived: sum of 2 quarters · filed 2018-02-28 | $602.00K derived: sum of 3 quarters · filed 2018-02-28 | -$264.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $562.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $679.00K derived: sum of 2 quarters · filed 2018-02-28 | -$187.00K derived: sum of 3 quarters · filed 2018-02-28 | $835.00K 10-K · filed 2018-02-28 |
| 2015-09-30 | $117.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$749.00K derived: sum of 2 quarters · filed 2016-11-02 | $273.00K 10-Q · filed 2016-11-02 | $333.00K derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | -$866.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $156.00K 10-Q · filed 2016-08-03 | $216.00K derived: sum of 3 quarters · filed 2017-03-06 | -$1.15M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $1.02M 10-Q · filed 2016-05-04 | $1.08M derived: sum of 2 quarters · filed 2017-03-06 | -$285.00K derived: sum of 3 quarters · filed 2017-03-06 | -$2.02M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$1.31M derived: sum of 2 quarters · filed 2017-03-06 | -$3.04M derived: sum of 3 quarters · filed 2017-03-06 | -$2.95M 10-K · filed 2017-03-06 |
| 2014-09-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$3.10M derived: sum of 2 quarters · filed 2015-11-06 | -$3.01M 10-Q · filed 2015-11-06 | -$1.69M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | -$1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$1.65M 10-Q · filed 2015-08-07 | -$320.00K derived: sum of 3 quarters · filed 2016-03-10 | $599.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $92.00K 10-Q · filed 2015-05-08 | $1.42M derived: sum of 2 quarters · filed 2016-03-10 | $2.34M derived: sum of 3 quarters · filed 2016-03-10 | $2.80M derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $2.24M derived: sum of 2 quarters · filed 2016-03-10 | $2.71M derived: sum of 3 quarters · filed 2016-03-10 | $2.44M 10-K · filed 2016-03-10 |
| 2013-09-30 | $919.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.38M derived: sum of 2 quarters · filed 2014-11-07 | $1.12M 10-Q · filed 2014-11-07 | $1.36M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $461.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $201.00K 10-Q · filed 2014-08-08 | $439.00K derived: sum of 3 quarters · filed 2015-03-13 | $404.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | -$260.00K 10-Q · filed 2014-05-12 | -$22.00K derived: sum of 2 quarters · filed 2015-03-13 | -$57.00K derived: sum of 3 quarters · filed 2015-03-13 | -$198.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $203.00K derived: sum of 2 quarters · filed 2015-03-13 | $62.00K derived: sum of 3 quarters · filed 2015-03-13 | $199.00K 10-K · filed 2015-03-13 |
| 2012-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$176.00K derived: sum of 2 quarters · filed 2013-11-12 | -$39.00K 10-Q · filed 2013-11-12 | |
| 2012-06-30 | -$141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$4.00K 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $137.00K 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | -$171.00K 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |